These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32691288)

  • 1. Microbiome response to diet: focus on obesity and related diseases.
    Delzenne NM; Rodriguez J; Olivares M; Neyrinck AM
    Rev Endocr Metab Disord; 2020 Sep; 21(3):369-380. PubMed ID: 32691288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diets naturally rich in polyphenols and/or long-chain n-3 polyunsaturated fatty acids differently affect microbiota composition in high-cardiometabolic-risk individuals.
    Vetrani C; Maukonen J; Bozzetto L; Della Pepa G; Vitale M; Costabile G; Riccardi G; Rivellese AA; Saarela M; Annuzzi G
    Acta Diabetol; 2020 Jul; 57(7):853-860. PubMed ID: 32114641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the Interaction of the Gut Microbiome with Host Metabolism and Cardiometabolic Health in Metabolic Syndrome.
    Galié S; Papandreou C; Arcelin P; Garcia D; Palau-Galindo A; Gutiérrez-Tordera L; Folch À; Bulló M
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome as a novel cardiovascular therapeutic target.
    Singh V; Yeoh BS; Vijay-Kumar M
    Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiome and metabolic syndrome.
    Dabke K; Hendrick G; Devkota S
    J Clin Invest; 2019 Oct; 129(10):4050-4057. PubMed ID: 31573550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome, endocrine control of gut barrier function and metabolic diseases.
    Régnier M; Van Hul M; Knauf C; Cani PD
    J Endocrinol; 2021 Feb; 248(2):R67-R82. PubMed ID: 33295880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients.
    Guo Y; Luo S; Ye Y; Yin S; Fan J; Xia M
    J Clin Endocrinol Metab; 2021 Jan; 106(1):64-79. PubMed ID: 33017844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of diet to gut microbiota and related host cardiometabolic health: diet-gut interaction in human health.
    Wan Y; Tang J; Li J; Li J; Yuan J; Wang F; Li D
    Gut Microbes; 2020 May; 11(3):603-609. PubMed ID: 31964203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
    Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
    Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
    Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
    World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Beneficial Effects of Lippia Citriodora Extract on Diet-Induced Obesity in Mice Are Associated with Modulation in the Gut Microbiota Composition.
    Diez-Echave P; Vezza T; Rodríguez-Nogales A; Hidalgo-Garcia L; Garrido-Mesa J; Ruiz-Malagon A; Molina-Tijeras JA; Romero M; Robles-Vera I; Leyva-Jiménez FJ; Lozano-Sanchez J; Arráez-Román D; Segura-Carretero A; Micol V; García F; Morón R; Duarte J; Rodríguez-Cabezas ME; Gálvez J
    Mol Nutr Food Res; 2020 Jul; 64(13):e2000005. PubMed ID: 32415899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis.
    Nagai M; Obata Y; Takahashi D; Hase K
    Int Immunopharmacol; 2016 Aug; 37():79-86. PubMed ID: 27133028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
    Wijdeveld M; Nieuwdorp M; IJzerman R
    Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome.
    Quigley EM; Abu-Shanab A; Murphy EF; Stanton C; Monsour HP
    Semin Liver Dis; 2016 Sep; 36(4):312-316. PubMed ID: 27997970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk.
    Meyer KA; Bennett BJ
    Curr Diab Rep; 2016 Oct; 16(10):93. PubMed ID: 27541295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.
    Delzenne NM; Neyrinck AM; Cani PD
    Microb Cell Fact; 2011 Aug; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21995448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.